Abstract
Acute spinal cord injury (ASCI) is a potentially disabling condition that has been extremely resistant to treatment. Emergency medical services (EMS) providers are often among the first members of the health care team to treat victims of ASCI. Although initial human and animal studies indicated that highdose corticosteroid therapy might be an effective therapy for ASCI, subsequent human and animal studies have not been able to reproduce the beneficial effects described in the earlier research. Highdose corticosteroid therapy for the treatment of ASCI was introduced to prehospital care in the 1980s. It was postulated that early administration of corticosteroids could limit the severity of neurologic deficit associated with ASCI by stabilizing neuronal membranes and reducing inflammation and swelling. The recommended corticosteroid for acute spinal cord injury was methylprednisolone (MP), and the doses were large. Prior to this recommendation, many EMS services carried standard doses, typically 125 mg, of MP for use in severe allergic
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
